SEC Form 4 · accession 0000878526-15-000079
NATUS MEDICAL INC · BABY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dong Chune Christopher Chung
Officer — Vice President Medical Affairs
Period of report
Oct 27, 2015
Accepted (ET)
Oct 29, 2015 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000878526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share | Oct 27, 2015 | M | 1,400 | $16.38 | A | 124,443 | D | |
| Common Stock, $0.001 par value per shareF1 | Oct 27, 2015 | S | 1,400 | $46.02 | D | 123,043 | D | |
| Common Stock, $0.001 par value per share | Oct 28, 2015 | M | 24,600 | $16.38 | A | 147,643 | D | |
| Common Stock, $0.001 par value per shareF2 | Oct 28, 2015 | S | 24,600 | $45.71 | D | 123,043 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonqualified Stock Option | $16.38 | Oct 27, 2015 | M | 1,400 | D | Jul 1, 2011 | Jun 1, 2017 | Common Stock | 1,400 | 24,600 | D |
| Nonqualified Stock Option | $16.38 | Oct 28, 2015 | M | 24,600 | D | Jul 1, 2011 | Jun 1, 2017 | Common Stock | 24,600 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $46.00 to $46.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $45.50 to $46.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.